Invenomic Capital Management’s H&R Block HRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-181,841
Closed -$6.42M 167
2022
Q2
$6.42M Sell
181,841
-641,803
-78% -$19.8M 0.46% 66
2022
Q1
$17.4M Buy
823,644
+319,775
+63% +$7.76M 1.86% 8
2021
Q4
$11.9M Buy
503,869
+111,936
+29% +$2.72M 2.54% 3
2021
Q3
$9.8M Buy
391,933
+37,170
+10% +$926K 3.18% 2
2021
Q2
$8.33M Buy
354,763
+4,188
+1% +$99.1K 1.99% 5
2021
Q1
$7.64M Buy
350,575
+34,677
+11% +$655K 1.7% 6
2020
Q4
$5.01M Buy
315,898
+39,883
+14% +$689K 1.28% 7
2020
Q3
$4.5M Buy
276,015
+257,115
+1,360% +$3.78M 2.48% 4
2020
Q2
$270K Buy
18,900
+8,326
+79% +$132K 0.2% 121
2020
Q1
$149K Buy
+10,574
New +$221K 0.12% 129

Other funds holding HRB

Invenomic Capital Management's HRB Position: Q3 2022 in Review

Invenomic Capital Management sold out of H&R Block (HRB) in Q3 2022, closing a stake of 181,841 shares — an estimated $6.42M sold.

Invenomic Capital Management first reported a position in HRB in Q1 2020 and held it in 10 quarters. The position peaked at $17.4M in Q1 2022. 458 funds tracked by Wall St. Rank hold HRB as of Q3 2022.

  • Invenomic Capital Management reported no remaining H&R Block position as of Q3 2022 after selling out during the quarter.
  • Invenomic Capital Management sold 181,841 H&R Block shares in Q3 2022, an estimated $6.42M.
  • Invenomic Capital Management first reported a position in H&R Block in Q1 2020 and held it in 10 quarters.
  • Invenomic Capital Management's H&R Block position peaked at $17.4M in Q1 2022.
  • 458 funds tracked by Wall St. Rank held H&R Block as of Q3 2022.

Based on Invenomic Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.